info icon

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C39
  • Hospital discharge: ICD-9 165
  • Hospital discharge: ICD-8 1639
  • Cause of death: ICD-10 C39
  • Cause of death: ICD-9 165
  • Cause of death: ICD-8 1639
  • Cancer registry: Topography ICD-O-3 C39
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

109

4. Check minimum number of events

None

109

5. Include endpoints

None

109

6. Filter based on genotype QC (FinnGen only)

105

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 105 31 74
Unadjusted period prevalence (%) 0.03 0.01 0.03
Median age at first event (years) 69.71 64.39 71.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
109
Matched controls
1090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J01AA02, ,
ATC
doxycycline; systemic
+∞
86.2
71
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
77.6
65
*
J01DB01, ,
ATC
cefalexin; oral
+∞
72.1
61
*
J01DA01, ,
ATC
[U] cefalexin
+∞
72.1
61
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
70.7
60
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
69.3
59
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
61.4
53
*
C399, ,
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
+∞
61.4
53
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
60.1
52
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
58.8
51
*
A98, ,
ICD-O-3
+∞
54.9
48
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
54.9
48
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
53.6
47
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
47.4
42
*
GD1AA, ,
ICD-O-3
+∞
46.2
41
*
C03CA01, ,
ATC
furosemide; systemic
+∞
44.9
40
*
130, ,
Kela drug reimbursment
Malignant tumour
+∞
42.5
38
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
42.5
38
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
42.5
38
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
42.5
38
*
UGC12, ,
ICD-O-3
+∞
41.3
37
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
41.3
37
*
C10AA01, ,
ATC
simvastatin; oral
+∞
41.3
37
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
41.3
37
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
40.1
36
*
M03BX02, ,
ATC
tizanidine; oral
+∞
40.1
36
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
40.1
36
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
38.9
35
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
36.5
33
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
36.5
33
*
ZXE10, ,
ICD-O-3
+∞
36.5
33
*
N05CF01, ,
ATC
zopiclone; oral
+∞
36.5
33
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
35.3
32
*
WX110, ,
ICD-O-3
+∞
35.3
32
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
35.3
32
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
34.2
31
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
34.2
31
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
34.2
31
*
J448, ,
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
+∞
33.0
30
*
C398, ,
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
33.0
30
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
33.0
30
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
33.0
30
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
33.0
30
*
CJE20, ,
ICD-O-3
+∞
33.0
30
*
M02AA07, ,
ATC
piroxicam; topical
+∞
31.8
29
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
31.8
29
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
30.7
28
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
30.7
28
*
WZC00, ,
ICD-O-3
+∞
30.7
28
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
29.5
27
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
29.5
27
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
29.5
27
*
A06AD11, ,
ATC
lactulose; oral
+∞
29.5
27
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
29.5
27
*
ZXD10, ,
ICD-O-3
+∞
29.5
27
*
SPAT1256, ,
ICD-O-3
+∞
29.5
27
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
28.4
26
*
C08CA01, ,
ATC
amlodipine; oral
+∞
28.4
26
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
28.4
26
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
28.4
26
*
SAA01, ,
ICD-O-3
+∞
27.2
25
*
ZXA00, ,
ICD-O-3
+∞
27.2
25
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
27.2
25
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
27.2
25
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
27.2
25
*
SPAT1263, ,
ICD-O-3
+∞
26.1
24
*
ZXE00, ,
ICD-O-3
+∞
26.1
24
*
B01AA03, ,
ATC
warfarin; systemic
+∞
26.1
24
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
26.1
24
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
24.9
23
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
24.9
23
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
24.9
23
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
24.9
23
*
I10, ,
ICD-O-3
+∞
24.9
23
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
24.9
23
*
R06AE07, ,
ATC
cetirizine; oral
+∞
24.9
23
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
24.9
23
*
N05BA04, ,
ATC
oxazepam; oral
+∞
24.9
23
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
24.9
23
*
R4110, ,
ICD-O-3
+∞
23.8
22
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
23.8
22
*
D381, ,
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
+∞
23.8
22
*
ZXD05, ,
ICD-O-3
+∞
23.8
22
*
S18, ,
ICD-O-3
+∞
23.8
22
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
23.8
22
*
EB1AA, ,
ICD-O-3
+∞
22.7
21
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
22.7
21
*
UJD10, ,
ICD-O-3
+∞
22.7
21
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
22.7
21
*
E0000UV, ,
ATC
+∞
22.7
21
*
SAA02, ,
ICD-O-3
+∞
22.7
21
*
SPAT1325, ,
ICD-O-3
+∞
22.7
21
*
R01AD09, ,
ATC
mometasone; nasal
+∞
22.7
21
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
22.7
21
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
21.6
20
*
H02AB07, ,
ATC
prednisone; oral
+∞
21.6
20
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
21.6
20
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
21.6
20
*
Z2221, ,
ICD-O-3
+∞
21.6
20
*
WX408, ,
ICD-O-3
+∞
21.6
20
*
N02AB03, ,
ATC
fentanyl; nasal, sublingual, transdermal
+∞
21.6
20
*
K021, ,
ICD-O-3
+∞
20.4
19
*
SPAT1249, ,
ICD-O-3
+∞
20.4
19
*
C349, ,
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
20.4
19
*
Z3231, ,
ICD-O-3
+∞
20.4
19
*
J90, ,
ICD-10 Finland
Pleural effusion, not elsewhere classified
+∞
20.4
19
*
SPAT1253, ,
ICD-O-3
+∞
20.4
19
*
R03BB04, ,
ATC
tiotropium bromide; inhalant
+∞
20.4
19
*
UJF32, ,
ICD-O-3
+∞
20.4
19
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
20.4
19
*
SFA10, ,
ICD-O-3
+∞
19.3
18
*
C09AA02, ,
ATC
enalapril; systemic
+∞
19.3
18
*
TPH04, ,
ICD-O-3
+∞
19.3
18
*
JN4BD, ,
ICD-O-3
+∞
19.3
18
*
R03AK03, ,
ATC
[U] fenoterol and ipratropium bromide
+∞
19.3
18
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
19.3
18
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
19.3
18
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
18.2
17
*
N06AB04, ,
ATC
citalopram; systemic
+∞
18.2
17
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
18.2
17
*
AA1AD, ,
ICD-O-3
+∞
18.2
17
*
N03AX16, ,
ATC
[U] pregabalin
+∞
18.2
17
*
C390, ,
ICD-10 Finland
Malignant neoplasm: Upper respiratory tract, part unspecified
+∞
18.2
17
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
18.2
17
*
ZXA05, ,
ICD-O-3
+∞
18.2
17
*
KMAK, ,
ICD-O-3
+∞
18.2
17
*
ZX120, ,
ICD-O-3
+∞
18.2
17
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
17.1
16
*
GD1QA, ,
ICD-O-3
+∞
17.1
16
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
17.1
16
*
D07AC13, ,
ATC
mometasone; topical
+∞
17.1
16
*
JN3AE, ,
ICD-O-3
+∞
17.1
16
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
17.1
16
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
17.1
16
*
C61, ,
ICD-10 Finland
Malignant neoplasm of prostate
+∞
17.1
16
*
GD1PA, ,
ICD-O-3
+∞
17.1
16
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
17.1
16
*
SAA03, ,
ICD-O-3
+∞
17.1
16
*
SFA20, ,
ICD-O-3
+∞
17.1
16
*
GD1UA, ,
ICD-O-3
+∞
16.0
15
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
16.0
15
*
A10BA02, ,
ATC
metformin; oral
+∞
16.0
15
*
FN1AC, ,
ICD-O-3
+∞
16.0
15
*
SPAT1301, ,
ICD-O-3
+∞
16.0
15
*
C341, ,
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
16.0
15
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
16.0
15
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
16.0
15
*
WZB00, ,
ICD-O-3
+∞
16.0
15
*
UKC02, ,
ICD-O-3
+∞
16.0
15
*
D07AC01, ,
ATC
betamethasone; topical
+∞
16.0
15
*
A28, ,
ICD-O-3
+∞
16.0
15
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
16.0
15
*
GA4YT, ,
ICD-O-3
+∞
16.0
15
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
14.9
14
*
D01BA02, ,
ATC
terbinafine; oral
+∞
14.9
14
*
XX3DW, ,
ICD-O-3
+∞
14.9
14
*
C01AA05, ,
ATC
digoxin; systemic
+∞
14.9
14
*
EB1HA, ,
ICD-O-3
+∞
14.9
14
*
G04CB01, ,
ATC
finasteride; oral
+∞
14.9
14
*
XKD00, ,
ICD-O-3
+∞
14.9
14
*
C349, 8000, 3
O3
+∞
14.9
14
*
ZXE20, ,
ICD-O-3
+∞
14.9
14
*
N05BA06, ,
ATC
lorazepam; systemic, sublingual
+∞
14.9
14
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
14.9
14
*
M01AX17, ,
ATC
nimesulide; oral
+∞
14.9
14
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
14.9
14
*
SPAT1153, ,
ICD-O-3
+∞
14.9
14
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
14.9
14
*
JN3BD, ,
ICD-O-3
+∞
14.9
14
*
Z024, ,
ICD-O-3
+∞
14.9
14
*
C09AA05, ,
ATC
ramipril; oral
+∞
14.9
14
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
14.9
14
*
Z3226, ,
ICD-O-3
+∞
14.9
14
*
N05CD07, ,
ATC
temazepam; oral
+∞
14.9
14
*
FM1AE, ,
ICD-O-3
+∞
14.9
14
*
WZC30, ,
ICD-O-3
+∞
14.9
14
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
13.8
13
*
H13, ,
ICD-O-3
+∞
13.8
13
*
C09CA06, ,
ATC
candesartan; oral
+∞
13.8
13
*
LC2BE, ,
ICD-O-3
+∞
13.8
13
*
J159, ,
ICD-10 Finland
Bacterial pneumonia, unspecified
+∞
13.8
13
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
13.8
13
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
13.8
13
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
13.8
13
*
C09CA01, ,
ATC
losartan; oral
+∞
13.8
13
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
13.8
13
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
13.8
13
*
C3499, ,
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
13.8
13
*
C349, 8140, 3
O3
+∞
13.8
13
*
WX290, ,
ICD-O-3
+∞
13.8
13
*
C10AA04, ,
ATC
fluvastatin; oral
+∞
13.8
13
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
13.8
13
*
C619, 8140, 3
O3
+∞
13.8
13
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
13.8
13
*
C349, 8070, 3
O3
+∞
13.8
13
*
WX404, ,
ICD-O-3
+∞
12.7
12
*
SDA03, ,
ICD-O-3
+∞
12.7
12
*
J069, ,
ICD-O-3
+∞
12.7
12
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
12.7
12
*
M01AC01, ,
ATC
piroxicam; systemic, rectal
+∞
12.7
12
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
12.7
12
*
SPAT1310, ,
ICD-O-3
+∞
12.7
12
*
AN1, ,
ICD-O-3
+∞
12.7
12
*
-1, ,
ICD-O-3
+∞
12.7
12
*
L28, ,
ICD-O-3
+∞
12.7
12
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
12.7
12
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
12.7
12
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
12.7
12
*
UJD02, ,
ICD-O-3
+∞
12.7
12
*
C3490, ,
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.7
12
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
12.7
12
*
XF400, ,
ICD-O-3
+∞
12.7
12
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
12.7
12
*
R104, ,
ICD-O-3
+∞
11.7
11
*
WX402, ,
ICD-O-3
+∞
11.7
11
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
11.7
11
*
KC1EE, ,
ICD-O-3
+∞
11.7
11
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
11.7
11
*
SDA02, ,
ICD-O-3
+∞
11.7
11
*
D07BC01, ,
ATC
betamethasone and antiseptics; topical
+∞
11.7
11
*
SPAT1250, ,
ICD-O-3
+∞
11.7
11
*
WF004, ,
ICD-O-3
+∞
11.7
11
*
FB1BD, ,
ICD-O-3
+∞
11.7
11
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
11.7
11
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
11.7
11
*
116, ,
Kela drug reimbursment
Prostate cancer
+∞
11.7
11
*
R33, ,
ICD-10 Finland
Retention of urine
+∞
11.7
11
*
I702, ,
ICD-10 Finland
Atherosclerosis of arteries of extremities
+∞
11.7
11
*
E000001, ,
ATC
+∞
11.7
11
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
11.7
11
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
11.7
11
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
11.7
11
*
SPAT1262, ,
ICD-O-3
+∞
11.7
11
*
EBA00, ,
ICD-O-3
+∞
11.7
11
*
FM1EE, ,
ICD-O-3
+∞
11.7
11
*
R05, ,
ICD-O-3
+∞
11.7
11
*
Z012, ,
ICD-O-3
+∞
11.7
11
*
WD125, ,
ICD-O-3
+∞
11.7
11
*
ZXA10, ,
ICD-O-3
+∞
11.7
11
*
SFA30, ,
ICD-O-3
+∞
10.6
10
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
10.6
10
*
C08DB01, ,
ATC
diltiazem; oral
+∞
10.6
10
*
R02, ,
ICD-O-3
+∞
10.6
10
*
C3419, ,
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
10.6
10
*
LCA06, ,
ICD-O-3
+∞
10.6
10
*
EB1SA, ,
ICD-O-3
+∞
10.6
10
*
WYA05, ,
ICD-O-3
+∞
10.6
10
*
A10BB12, ,
ATC
glimepiride; oral
+∞
10.6
10
*
JN4AD, ,
ICD-O-3
+∞
10.6
10
*
SPAT1312, ,
ICD-O-3
+∞
10.6
10
*
R03AC12, ,
ATC
salmeterol; inhalant
+∞
10.6
10
*
SPAT1222, ,
ICD-O-3
+∞
10.6
10
*
Z712, ,
ICD-O-3
+∞
10.6
10
*
A02BA04, ,
ATC
nizatidine; systemic
+∞
10.6
10
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
10.6
10
*
H258, ,
ICD-10 Finland
Other senile cataract
+∞
10.6
10
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
10.6
10
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
10.6
10
*
I471, ,
ICD-10 Finland
Supraventricular tachycardia
+∞
10.6
10
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
10.6
10
*
WX320, ,
ICD-O-3
+∞
10.6
10
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
10.6
10
*
213, ,
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
+∞
10.6
10
*
J449, ,
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
+∞
10.6
10
*
N06AB10, ,
ATC
escitalopram; oral
+∞
10.6
10
*
L02AE02, ,
ATC
leuprorelin; implant, parenteral
+∞
10.6
10
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
10.6
10
*
XJH00, ,
ICD-O-3
+∞
10.6
10
*
SPAT1223, ,
ICD-O-3
+∞
9.5
9
*
N40, ,
ICD-O-3
+∞
9.5
9
*
C03EB01, ,
ATC
furosemide and potassium-sparing agents; systemic
+∞
9.5
9
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
9.5
9
*
B01AB10, ,
ATC
tinzaparin; parenteral
+∞
9.5
9
*
SDE03, ,
ICD-O-3
+∞
9.5
9
*
C09BA02, ,
ATC
enalapril and diuretics; systemic
+∞
9.5
9
*
PH2AE, ,
ICD-O-3
+∞
9.5
9
*
117, ,
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
9.5
9
*
Z760, ,
ICD-O-3
+∞
9.5
9
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
9.5
9
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
9.5
9
*
D82, ,
ICD-O-3
+∞
9.5
9
*
M545, ,
ICD-O-3
+∞
9.5
9
*
T90, ,
ICD-O-3
+∞
9.5
9
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
9.5
9
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
9.5
9
*
J01MA14, ,
ATC
moxifloxacin; systemic
+∞
9.5
9
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
9.5
9
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
9.5
9
*
QAE10, ,
ICD-O-3
+∞
9.5
9
*
R03DA04, ,
ATC
theophylline; systemic, rectal
+∞
9.5
9
*
R060, ,
ICD-O-3
+∞
9.5
9
*
D01AC02, ,
ATC
miconazole; topical
+∞
9.5
9
*
J440, ,
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
+∞
9.5
9
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
9.5
9
*
Z3229, ,
ICD-O-3
+∞
9.5
9
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
9.5
9
*
L08, ,
ICD-O-3
+∞
9.5
9
*
C03DA01, ,
ATC
spironolactone; oral
+∞
9.5
9
*
D07AB08, ,
ATC
desonide; topical
+∞
9.5
9
*
WX302, ,
ICD-O-3
+∞
9.5
9
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
9.5
9
*
C399, 8000, 3
O3
+∞
9.5
9
*
WX700, ,
ICD-O-3
+∞
9.5
9
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
9.5
9
*
GD1BD, ,
ICD-O-3
+∞
9.5
9
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
8.4
8
*
C3411, ,
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
8.4
8
*
N06AA09, ,
ATC
amitriptyline; systemic
+∞
8.4
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.4
8
*
K0530, ,
ICD-O-3
+∞
8.4
8
*
GA1AE, ,
ICD-O-3
+∞
8.4
8
*
50099, ,
ICD-8 Finland
Hypertrophy of tonsils and adenoids
+∞
8.4
8
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
8.4
8
*
XLD00, ,
ICD-O-3
+∞
8.4
8
*
J189, ,
ICD-O-3
+∞
8.4
8
*
WX002, ,
ICD-O-3
+∞
8.4
8
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
8.4
8
*
R042, ,
ICD-10 Finland
Haemoptysis
+∞
8.4
8
*
I500, ,
ICD-10 Finland
Congestive heart failure
+∞
8.4
8
*
I269, ,
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
+∞
8.4
8
*
GD5BD, ,
ICD-O-3
+∞
8.4
8
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
8.4
8
*
S29, ,
ICD-O-3
+∞
8.4
8
*
201, ,
Kela drug reimbursment
Chronic cardiac insufficiency
+∞
8.4
8
*
M01AH02, ,
ATC
rofecoxib; oral
+∞
8.4
8
*
K85, ,
ICD-O-3
+∞
8.4
8
*
SPAT1148, ,
ICD-O-3
+∞
8.4
8
*
R568, ,
ICD-10 Finland
Other and unspecified convulsions
+∞
8.4
8
*
UJF45, ,
ICD-O-3
+∞
8.4
8
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
8.4
8
*
C798, ,
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
A01AB09, ,
ATC
miconazole; local oral
+∞
8.4
8
*
K409, ,
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
+∞
8.4
8
*
SDA01, ,
ICD-O-3
+∞
8.4
8
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
8.4
8
*
WX100, ,
ICD-O-3
+∞
8.4
8
*
H02, ,
ICD-O-3
+∞
8.4
8
*
R03AC13, ,
ATC
formoterol; inhalant
+∞
8.4
8
*
KE1BE, ,
ICD-O-3
+∞
8.4
8
*
M01AX05, ,
ATC
glucosamine; oral
+∞
8.4
8
*
C3412, ,
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.4
8
*
C09AA03, ,
ATC
lisinopril; oral
+∞
8.4
8
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
8.4
8
*
C348, ,
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
8.4
8
*
WF002, ,
ICD-O-3
+∞
8.4
8
*
81, ,
ICD-O-3
+∞
8.4
8
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
8.4
8
*
M751, ,
ICD-O-3
+∞
8.4
8
*
JKA21, ,
ICD-O-3
+∞
8.4
8
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
8.4
8
*
J010, ,
ICD-O-3
+∞
8.4
8
*
J01MA01, ,
ATC
ofloxacin; systemic
+∞
8.4
8
*
M01AH01, ,
ATC
celecoxib; oral
+∞
8.4
8
*
J01EE01, ,
ATC
sulfamethoxazole and trimethoprim; systemic
+∞
8.4
8
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
8.4
8
*
M796, ,
ICD-O-3
+∞
8.4
8
*
R03BB01, ,
ATC
ipratropium bromide; inhalant
+∞
8.4
8
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
8.4
8
*
I250, ,
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
+∞
7.4
7
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
7.4
7
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
7.4
7
*
C10AA03, ,
ATC
pravastatin; oral
+∞
7.4
7
*
KE1AT, ,
ICD-O-3
+∞
7.4
7
*
WZA90, ,
ICD-O-3
+∞
7.4
7
*
WF049, ,
ICD-O-3
+∞
7.4
7
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
7.4
7
*
EBA05, ,
ICD-O-3
+∞
7.4
7
*
ZX012, ,
ICD-O-3
+∞
7.4
7
*
A29, ,
ICD-O-3
+∞
7.4
7
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
7.4
7
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
7.4
7
*
C07AA07, ,
ATC
sotalol; systemic
+∞
7.4
7
*
ZXD20, ,
ICD-O-3
+∞
7.4
7
*
C09DA01, ,
ATC
losartan and diuretics; oral
+∞
7.4
7
*
M09AA72, ,
ATC
quinine, combinations with psycholeptics; systemic
+∞
7.4
7
*
A10AB05, ,
ATC
insulin aspart; parenteral
+∞
7.4
7
*
R42, ,
ICD-O-3
+∞
7.4
7
*
SPAT1230, ,
ICD-O-3
+∞
7.4
7
*
L03, ,
ICD-O-3
+∞
7.4
7
*
R2130, ,
ICD-O-3
+∞
7.4
7
*
R29, ,
ICD-O-3
+∞
7.4
7
*
JN3AD, ,
ICD-O-3
+∞
7.4
7
*
C07AA05, ,
ATC
propranolol; systemic
+∞
7.4
7
*
G04BD04, ,
ATC
oxybutynin; oral, transdermal
+∞
7.4
7
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
7.4
7
*
SPAT1254, ,
ICD-O-3
+∞
7.4
7
*
WW200, ,
ICD-O-3
+∞
7.4
7
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
7.4
7
*
R5110, ,
ICD-O-3
+∞
7.4
7
*
R074, ,
ICD-O-3
+∞
7.4
7
*
A04AA02, ,
ATC
granisetron; systemic, transdermal
+∞
7.4
7
*
N05AH04, ,
ATC
quetiapine; oral
+∞
7.4
7
*
C4431, ,
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.4
7
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
7.4
7
*
J209, ,
ICD-O-3
+∞
7.4
7
*
Z017, ,
ICD-O-3
+∞
7.4
7
*
SPAT1156, ,
ICD-O-3
+∞
7.4
7
*
L04AX03, ,
ATC
methotrexate; systemic
+∞
7.4
7
*
R03DC03, ,
ATC
montelukast; oral
+∞
7.4
7
*
I842, ,
ICD-10 Finland
Internal hemorrhoids without complication
+∞
7.4
7
*
C3410, ,
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.4
7
*
M480, ,
ICD-10 Finland
Spinal stenosis
+∞
7.4
7
*
D07AD01, ,
ATC
clobetasol; topical
+∞
7.4
7
*
J01FA15, ,
ATC
telithromycin; oral
+∞
7.4
7
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
7.4
7
*
TPH07, ,
ICD-O-3
+∞
7.4
7
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
7.4
7
*
SPAT1216, ,
ICD-O-3
+∞
7.4
7
*
SFC01, ,
ICD-O-3
+∞
7.4
7
*
R06AX22, ,
ATC
ebastine; oral
+∞
7.4
7
*
XG412, ,
ICD-O-3
+∞
7.4
7
*
K210, ,
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
+∞
7.4
7
*
Z871, ,
ICD-O-3
+∞
7.4
7
*
FM1DE, ,
ICD-O-3
+∞
7.4
7
*
TKE00, ,
ICD-O-3
+∞
7.4
7
*
P20, ,
ICD-O-3
+∞
7.4
7
*
M255, ,
ICD-O-3
+∞
7.4
7
*
A04, ,
ICD-O-3
+∞
7.4
7
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
7.4
7
*
WX602, ,
ICD-O-3
+∞
7.4
7
*
A07EC01, ,
ATC
sulfasalazine; oral, rectal
+∞
7.4
7
*
R2110, ,
ICD-O-3
+∞
6.3
6
*
ZX080, ,
ICD-O-3
+∞
6.3
6
*
J448, ,
ICD-O-3
+∞
6.3
6
*
SDE02, ,
ICD-O-3
+∞
6.3
6
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
6.3
6
*
Z014, ,
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
6.3
6
*
J370, ,
ICD-10 Finland
Chronic laryngitis
+∞
6.3
6
*
C3400, ,
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
11, ,
ICD-O-3
+∞
6.3
6
*
R03AL01, ,
ATC
fenoterol and ipratropium bromide; inhalant
+∞
6.3
6
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
6.3
6
*
E000002, ,
ATC
+∞
6.3
6
*
J948, ,
ICD-10 Finland
Other specified pleural conditions
+∞
6.3
6
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
6.3
6
*
SPAT1053, ,
ICD-O-3
+∞
6.3
6
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
6.3
6
*
R06AX13, ,
ATC
loratadine; oral
+∞
6.3
6
*
JEA00, ,
ICD-O-3
+∞
6.3
6
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
6.3
6
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
6.3
6
*
E7801, ,
ICD-O-3
+∞
6.3
6
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
6.3
6
*
KH1AE, ,
ICD-O-3
+∞
6.3
6
*
S223, ,
ICD-10 Finland
Fracture of rib
+∞
6.3
6
*
TPH15, ,
ICD-O-3
+∞
6.3
6
*
S97, ,
ICD-O-3
+∞
6.3
6
*
SPAT1283, ,
ICD-O-3
+∞
6.3
6
*
J459, ,
ICD-O-3
+∞
6.3
6
*
K0510, ,
ICD-O-3
+∞
6.3
6
*
SDA04, ,
ICD-O-3
+∞
6.3
6
*
N06DX01, ,
ATC
memantine; oral
+∞
6.3
6
*
ZYC01, ,
ICD-O-3
+∞
6.3
6
*
111, ,
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
6.3
6
*
M545, ,
ICD-10 Finland
Low back pain
+∞
6.3
6
*
M480, ,
ICD-O-3
+∞
6.3
6
*
L01BA01, ,
ATC
methotrexate; systemic
+∞
6.3
6
*
AA1BD, ,
ICD-O-3
+∞
6.3
6
*
R073, ,
ICD-O-3
+∞
6.3
6
*
SPAT1260, ,
ICD-O-3
+∞
6.3
6
*
R53, ,
ICD-O-3
+∞
6.3
6
*
Y83, ,
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
A10AC01, ,
ATC
insulin (human); parenteral
+∞
6.3
6
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
6.3
6
*
A02BA03, ,
ATC
famotidine; systemic
+∞
6.3
6
*
K78, ,
ICD-O-3
+∞
6.3
6
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
6.3
6
*
LX1AE, ,
ICD-O-3
+∞
6.3
6
*
YX9AD, ,
ICD-O-3
+∞
6.3
6
*
M01AB01, ,
ATC
indometacin; systemic, rectal
+∞
6.3
6
*
HA1AA, ,
ICD-O-3
+∞
6.3
6
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
6.3
6
*
FN1BC, ,
ICD-O-3
+∞
6.3
6
*
K449, ,
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
+∞
6.3
6
*
SPAT1217, ,
ICD-O-3
+∞
6.3
6
*
K0382, ,
ICD-O-3
+∞
6.3
6
*
WX892, ,
ICD-O-3
+∞
6.3
6
*
J949, ,
ICD-10 Finland
Pleural condition, unspecified
+∞
6.3
6
*
SPAT1149, ,
ICD-O-3
+∞
6.3
6
*
KCD02, ,
ICD-O-3
+∞
6.3
6
*
B01AC06, ,
ATC
acetylsalicylic acid; oral
+∞
6.3
6
*
R83, ,
ICD-O-3
+∞
6.3
6
*
HA1AE, ,
ICD-O-3
+∞
6.3
6
*
E1100, ,
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
+∞
6.3
6
*
A02BD03, ,
ATC
lansoprazole, amoxicillin and metronidazole; systemic
+∞
6.3
6
*
D06BX01, ,
ATC
metronidazole; topical
+∞
6.3
6
*
GD1AD, ,
ICD-O-3
+∞
6.3
6
*
R238, ,
ICD-O-3
+∞
6.3
6
*
WD105, ,
ICD-O-3
+∞
6.3
6
*
GDC00, ,
ICD-O-3
+∞
6.3
6
*
R748, ,
ICD-10 Finland
Abnormal levels of other serum enzymes
+∞
6.3
6
*
WX105, ,
ICD-O-3
+∞
6.3
6
*
SPAT1324, ,
ICD-O-3
+∞
6.3
6
*
SAD01, ,
ICD-O-3
+∞
6.3
6
*
ZY020, ,
ICD-O-3
+∞
6.3
6
*
N179, ,
ICD-10 Finland
Acute renal failure, unspecified
+∞
6.3
6
*
A03FA02, ,
ATC
cisapride; oral, rectal
+∞
6.3
6
*
JN1AE, ,
ICD-O-3
+∞
6.3
6
*
C07AB03, ,
ATC
atenolol; systemic
+∞
6.3
6
*
S01AX11, ,
ATC
[U] ofloxacin
+∞
6.3
6
*
D01AE16, ,
ATC
amorolfine; topical
+∞
6.3
6
*
M058, ,
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
6.3
6
*
A12BA01, ,
ATC
potassium chloride; oral
+∞
6.3
6
*
R74, ,
ICD-O-3
+∞
6.3
6
*
N07CA01, ,
ATC
betahistine; oral
+∞
6.3
6
*
C7930, ,
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
20
9.17
7.93
1.8
1.2
—
—
—
0
0
37
657
0.34
6.72
3.7
5.2
2.47
2.53
mmol/l
0.15
32
588
10
7
15.54
6.53
1.4
1.3
36.28
25.87
g/l
—
10
7
9
5
19.41
6.38
1.6
1.6
35.68
10.43
ug/l
—
9
5
9
7
13.85
5.69
1.3
1.1
—
—
—
0
0
40
650
0.39
5.20
4.7
5.0
5.74
6.13
mmol/l
1.94
34
564
47
692
0.44
4.32
22.3
14.3
—
—
—
0
0
7
7
10.57
4.07
1.3
1.0
—
—
—
0
0
6
5
12.58
3.81
1.3
1.0
5.08
7.32
mmol/l
—
6
5
8
12
7.09
3.74
2.5
1.2
75.88
93.96
u/ml
—
8
12
33
539
0.44
3.70
30.5
17.0
14.34
15.46
%
2.29
33
523
30
502
0.44
3.52
3.3
3.8
15.36
14.92
pmol/l
0.47
30
432
16
335
0.39
3.17
1.9
2.1
87.29
90.56
pmol/l
—
7
181
6
184
0.29
3.05
3.5
3.7
—
—
—
0
0
6
181
0.29
2.89
2.5
3.7
—
—
—
0
0
9
221
0.35
2.87
2.6
3.2
6.71
7.20
mmol/l
—
9
183
5
7
7.41
2.57
1.4
1.1
156.24
60.77
pmol/l
—
5
7
32
486
0.52
2.51
4.2
4.2
—
—
—
0
0
17
316
0.45
2.38
7.6
4.3
2.78
2.46
ug/l
0.17
17
270
11
42
2.80
2.22
13.9
8.4
—
—
—
0
0
5
10
5.18
2.09
1.4
4.0
—
—
—
0
0
10
39
2.72
2.00
14.3
7.6
0.49
0.80
%
—
10
39
10
39
2.72
2.00
14.1
7.7
0.87
1.47
%
—
10
39
18
94
2.10
1.94
2.6
1.6
—
—
—
0
0
12
232
0.46
1.80
3.4
4.3
—
—
—
0
0
0
46
0.00
1.75
0.0
1.2
—
—
—
0
0
10
40
2.65
1.72
1.5
1.1
—
—
—
0
0
18
99
1.98
1.70
2.9
1.9
0.81
0.83
mmol/l
0.36
18
91
15
79
2.04
1.58
13.8
5.7
102.27
103.62
mmol/l
0.29
15
79
35
476
0.61
1.58
4.2
4.0
—
—
—
0
0
8
160
0.46
1.38
5.0
2.5
0.94
0.85
ug/l
—
8
111
23
337
0.60
1.37
4.2
4.1
49.47
55.93
ng/l
0.15
15
255
28
195
1.59
1.21
3.0
1.7
—
—
—
0
0
12
200
0.55
1.13
1.6
1.6
21.81
18.80
nmol/l
0.48
12
167
7
32
2.27
1.10
2.3
1.9
8.63
14.43
nmol/l
—
7
27
19
272
0.63
0.99
4.7
3.7
—
5.85
—
0
13
27
197
1.49
0.94
5.4
3.9
—
—
—
0
0
0
26
0.00
0.79
0.0
8.3
—
—
—
0
0
5
27
1.89
0.69
21.8
7.8
—
—
—
0
0
19
140
1.43
0.64
8.3
5.3
—
—
—
0
0
8
49
1.68
0.64
1.9
2.5
0.15
0.19
g/l
—
8
35
10
67
1.54
0.51
14.1
6.8
115.50
123.88
g/l
—
10
67
19
147
1.35
0.49
5.8
3.2
86.11
82.66
%
0.22
19
140
20
247
0.77
0.44
2.7
2.7
—
—
—
0
0
5
33
1.54
0.42
23.8
7.5
27.40
24.02
mmol/l
—
5
33
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.4
—
105.47
—
0
15
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
0
15
0.00
0.41
0.0
2.4
—
4.15
—
0
15
0
16
0.00
0.41
0.0
5.8
—
10.19
—
0
16
0
16
0.00
0.41
0.0
5.8
—
105.12
—
0
16
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
9
68
1.35
0.39
1.9
2.3
25.22
7.95
umol/l
—
9
57
5
76
0.64
0.37
2.6
1.7
—
—
—
0
0
11
82
1.38
0.35
1.5
1.9
—
—
—
0
0
6
44
1.38
0.35
3.3
1.5
—
—
—
0
0
12
154
0.75
0.35
4.1
3.4
193.33
189.30
ng/l
0.01
12
124
5
37
1.37
0.24
2.8
1.7
—
—
—
0
0
5
41
1.23
0.22
1.8
2.4
6.98
11.92
g/l
—
5
36
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
16.64
—
0
7
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
5.68
—
0
12
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
487.75
—
0
8
28
309
0.87
0.20
5.1
5.4
9.94
9.02
%
0.61
28
276
5
66
0.75
0.17
9.6
2.9
—
—
—
0
0
28
306
0.89
0.17
5.1
5.1
2.75
2.94
%
0.15
28
273
6
77
0.77
0.16
1.8
2.1
78.08
61.99
e9/l
—
6
64
34
316
1.11
0.15
11.6
4.8
1.20
1.21
mmol/l
0.23
34
274
8
97
0.81
0.14
5.4
2.3
24.00
23.23
%
—
8
87
20
221
0.88
0.14
2.5
2.1
65.45
80.20
u/l
0.29
20
201
16
179
0.88
0.13
3.3
2.6
—
—
—
0
0
29
312
0.90
0.13
5.0
5.3
22.29
25.47
%
0.89
29
280
22
201
1.12
0.12
3.4
1.9
—
—
—
0
0
28
298
0.92
0.10
5.1
5.1
0.69
0.63
%
0.22
28
269
29
307
0.92
0.09
4.9
5.0
59.96
59.14
%
0.13
29
276
8
92
0.86
0.07
1.4
1.3
—
—
—
0
0
16
148
1.10
0.06
5.8
3.5
—
—
—
0
0
10
110
0.90
0.05
2.2
1.7
28.31
30.01
s
—
10
105
35
361
0.96
0.04
14.7
17.5
1.47
1.44
inr
0.05
11
103
15
156
0.96
0.00
1.3
1.4
—
—
—
0
0
29
291
1.00
0.00
5.2
5.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
69
1.02
-0.00
2.7
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
6.97
—
0
7
6
62
0.97
-0.00
2.7
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
12.97
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
6.2
3.8
2.13
1.71
mmol/l
—
6
52
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
71
0.98
-0.00
1.3
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
11.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.0
—
67.83
—
0
9
0
5
0.00
-0.00
0.0
1.6
—
1.66
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
26.60
—
0
5
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
2050.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
34.22
—
0
9
6
64
0.93
-0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.4
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).